Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study TXA107977, a Long-Term Safety Study of a Combination Product Containing Sumatriptan Succinate and Naproxen Sodium for the Treatment of Migraine in Adolescents

NCT00488514 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00488514
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00488514 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study TXA107977, a Long-Term Safety Study of a Combination Product Containing Sumatriptan Succinate and Naproxen Sodium for the Treatment of Migraine in Adolescents
Lead sponsor
GlaxoSmithKline
Phase
Phase 3
Overall status
Completed
Start date
July 13, 2007
Completion date
August 20, 2009
Enrollment
656 (actual)
Sites
77

Conditions

As the registry lists them; a condition with its own page is linked.

migraine disorders